Reduction noted in 24-hour systolic BP at 36 weeks with treatment at 5, 10, 15 mg tirzepatide versus placebo
eHealthcare Solutions (EHS) manages advertising on this website.
We use cookies to ensure that we give you the best experience on our website.
By continuing, you agree to the use of cookies as per the EHS Privacy PolicyOk